XCF Global, Inc. SAFX

Healthcare SIC 2860 - Industrial Organic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing › Other Basic Organic Chemical Manufacturing derived Nasdaq

Last close 0.16 2026-10-23
Market cap $65.5M 2026-06-30 share count
52-week range 0.12 - 1.27

Valuation FY2025 figures against the last close

P/S3.1x
P/E0.3x
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS0.52

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023
Revenue $20.8M$0—
Cost of revenue $24.6M——
Gross profit -$3.8M——
SG&A $22.4M$18.2M—
Total operating expenses $64.1M$21.2M—
Operating income -$67.9M-$21.2M—
Interest expense $9.2M$2.9M—
Net income $74.0M-$24.1M—
EPS, basic 0.52——
EPS, diluted 0.52——
Shares, diluted (wtd. avg.) 142.3M——

Balance sheet

Fiscal year FY2025FY2024FY2023
Cash and equivalents $154.9K$407.2K—
Receivables $24.6M——
Inventory $338.0K——
Total current assets $27.6M$1.4M—
Property, plant and equipment $390.3M$351.7M—
Total assets $419.5M$354.6M—
Accounts payable $40.3M$8.5M—
Short-term debt $176.2K$176.2K—
Total current liabilities $249.0M$180.4M—
Long-term debt $124.0M——
Total liabilities $381.8M$313.2M—
Retained earnings -$16.7M-$29.0M—
Total equity $37.7M$41.4M$29.7M

Cash flow

Fiscal year FY2025FY2024FY2023
Operating cash flow -$17.9M-$11.1M—
Stock-based compensation $8.8M——
Capital expenditure —$28.7M—
Investing cash flow -$1.6M-$28.9M—
Financing cash flow $19.2M$40.3M—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-039112.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -25M 0 25M 50M 75M Revenue, FY2024: 0 Net income, FY2024: -24.1M Revenue, FY2025: 20.8M Gross profit, FY2025: -3.8M Net income, FY2025: 74M FY2023 FY2024 FY2025
Fiscal year FY2023FY2024FY2025
Revenue — $0 $20.8M
Gross profit — — -$3.8M
Net income — -$24.1M $74.0M

Recent filings and events

  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Other event Item 8.01
  • Material agreement signed Item 1.01
  • Unregistered share sale Item 3.02
  • Material agreement signed Item 1.01
  • Unregistered share sale Item 3.02
  • Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02
  • Material agreement signed Item 1.01
  • Unregistered share sale Item 3.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $24.02B — -5.2%
LYB LyondellBasell Industries N.V. $21.47B — -9.7%
WLK WESTLAKE CORP $8.25B — -8.0%
NEU NEWMARKET CORP $8.01B 19.6x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.65B 42.0x 3.5%
REX REX AMERICAN RESOURCES Corp $1.32B 15.9x 1.2%
GPRE Green Plains Inc. $979.9M — 16.0%
WLKP Westlake Chemical Partners LP $745.5M — 2.7%